Controversy sells, and the media knows it. A lot of the information we hear, see and read about ADHD and ADHD treatment is either misleading or meant to scare us.
Netflix’s “Take Your Pills”, a new documentary (interview with producers) is no exception. This is why I am upset: The film, despite raising many legitimate concerns, contributes to confusion, stigma, and fear surrounding stimulant medication. Many of the experts featured either have no background in research, benefit directly from spreading fear and misinformation about ADHD treatment or are not qualified to speak on these subjects.
This is a problem because — as this study showed (- “Inaccurate media reports surrounding ADHD [have] have a major effect on parental decision-making” when it comes treatment.
Stimulant medication research is proving to be a very popular topic. Your doctor and you can discuss the facts with your doctor so that you can make an informed decision about what’s best for you.
This is Dr. Hallowell’s complete response to “Take Your Pills”
Dr. Hallowell is a psychiatrist and leading ADHD expert who’s written over 20 books on ADHD, including “Driven to Distraction” and “Delivered From Distraction” and is finishing up his memoir, which you can pre-order here: /
Documentaries are not peer-reviewed. Not all research studies are the same.
This guide will help you understand research studies:
These reliable resources provide information on ADHD and ADHD treatment:
ADHD facts: /
What we know so far about the long-term effects ADHD medication/
Why dosage is importantTypes of ADHD medication:How stimulants can help ADHD (Sci Show includes research):
/>”Getting Ahead of ADHD” by Dr. Joel T. Nigg (fantastic book on treating childhood ADHD, includes non-medication options & talks about meds starting p224): =
The difference in the effects of methamphetamines and amphetamines is f
What causes addiction? />And here is a systematic review that includes 69 recent (2011-2016) studies related to ADHD treatment: /
Kemper, A. R., Maslow, G. R., Hill, S., Namdari, B., Allen LaPointe, N. M., Goode, A. P., … Sanders, G. D. (2018). Attention Deficit Hyperactivity disorder: Treatment and Diagnosis in Children and Adolescents. Agency for Healthcare Research and Quality (US) Rockville (MD). Retrieved from /
Clavenna, A., & Bonati, M. (2017). Pediatric pharmacoepidemiology: safety and effectiveness for ADHD medicines. Expert Opinion on Drug Safety, 16(12), 1335-1345. 4
Merkel, R. L., & Kuchibhatla, A. (2009). Part I: Safety of stimulant treatment for attention deficit hyperactivity disorder Expert Opinion on Drug Safety, 8(6), 655-668. 6
Merkel, R. L. (2010). Part II: Safety of stimulant treatment for attention deficit hyperactivity disorder. Expert Opinion on Drug Safety, 9(6), 917-935. 8
Swanson, J. M., Arnold, L. E., Molina, B. S., Sibley, M. H., Hechtman, L. T., Hinshaw, S. P., Abikoff, H. B., Stehli, A. , Owens, E. B., Mitchell, J. T., Nichols, Q. , Howard, A. , Greenhill, L. L., Hoza, B. , Newcorn, J. H., Jensen, P. S., Vitiello, B. , Wigal, T. , Epstein, J. N., Tamm, L. , Lakes, K. D., Waxmonsky, J. , Lerner, M. , Etcovitch, J. , Murray, D. W., Muenke, M. , Acosta, M. T., Arcos-Burgos, M. , Pelham, W. E., Kraemer, H. C., , , Severe, J. B., Richters, J. , Vereen, D. , Elliott, G. R., Wells, K. C., Conners, C. K., March, J. , Cantwell, D. P., Gibbons, R. D., Marcus, S. , Hur, K. , Hanley, T. and Stern, K. (2017), Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatr, 58: 663-678. doi: 10.1111/jcpp. 12684